Navigation Links
Warfarin’s Anti-clotting Property May Cause Hemorrhagic Stroke

Warfarin, an anti-clotting drug given to patients suffering from atrial fibrillation has proved effective //by reducing the number of strokes due to clotting.

However, its anti-clotting property has led to an increase in the number of strokes caused by bleeding to the brain particularly in patients over the age of 80, according to a new study.

Warfarin was earlier used as rat poison, after research in the nineties suggested Warfarin reduced the risk of ischemic stroke it became a standard treatment for people suffering from atrial fibrillation.

Matthew Flaherty, the lead researcher and a neurologist at the University of Cincinnati in Ohio, said the study results don’t necessarily mean that use of warfarin should be given up, but motivate physicians to make sure that the drug is being used appropriately.

"Doctors can use these findings to make sure they are weighing the risks and benefits of warfarin use for their patients," he said.

“The benefits of anti-clotting drugs are "undeniable" for some patients, such as those who have had blood clots,” Dr. Flaherty said.

The researcher said more research was needed to find anti-coagulants safer than warfarin to help patients who suffer from hemorrhagic strokes.

All cases of intracerebral hemorrhage (bleeding inside the brain) in the Cincinnati area between 1988 and 1999 were examined by the study. The cases connected with the use of blood-thinning drugs soared to 4.4 cases per 100,000 people by 1999 from 0.8 cases per 100,000 in 1988. In comparison, the rate of hemorrhagic strokes associated to warfarin use, rose to 45.9 per 100,000 in 1999 from 2.5 per 100,000 in 1988.

The study notes that, between 1993 and 1999, the rate of ischemic stroke in patients suffering from atrial fibrillation remained fixed at about 22 per 100,000. But previous research has shown that warfarin use has halved the rate of ischemic stroke in pat ients with atrial fibrillation.

Warfarin is known by its brand name Coumadin, which is a product of Bristol Myers Squibb.

Warfarin is used to prevent clotting in the deep-seated veins of the lower leg (deep vein thrombosis), and also to prevent pulmonary embolism in patients having chronic obstructive pulmonary disorder (COPD).


Related medicine news :

1. Aspirin surpasses Modern Anti-clotting Drugs
2. Fruits And Vegetables Have Arthritis Risk Reducing Property
3. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
4. Opposition against Amendments in the Intellectual Property Law
5. Is Diabetes the Leading Cause of Kidney Failure in India
6. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
7. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
8. Breast Cancer Surgery Causes Psychological problems
9. Arthritis Drug May Cause Liver Damage
10. Causes of weakness in the aged
11. Gene Mutation Causes Ovarian Failure
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... Florida Hospital Tampa is the first health care provider ... state of Florida. , vBloc® Therapy is a vagal blocking therapy, delivered via the Maestro® ... body mass index (BMI) of at least 40 to 45 kg, or a BMI of ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one ... Surgery, has been named by MedEsthetics magazine as the Best Single Physician Practice in ... among the many elite aesthetic physicians honored by the industry publication. , Dr. ...
(Date:12/1/2015)... Delaware (PRWEB) , ... December 01, 2015 , ... ... winner at the 7th Annual 2015 Golden Bridge Business Awards under the New ... is a zero capex web based sample management software that helps ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... radiographic technicians must mark the film for accurate interpretation by the radiologist. The ... Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate this ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... it has been awarded a fixed price per sprint agile development contract to ... at $34 million over five years, provides software engineering, infrastructure, as well as ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015 WellStar Health System has ... Texas -based Tenet Healthcare,s five metro ... approved the strategic move following the conclusion of the ... clinical care models and patient safety programs that have ... to new communities. --> ...
(Date:12/1/2015)... , Dec. 1, 2015  Eyeon Therapeutics has ... dry eye treatments based on a charged hydrophilic ... delivery CDMO.  The product has been shown to ... previously published.  Mark Mitchnick , MD, CEO ... protection to additional polymers in conjunction with a ...
(Date:12/1/2015)... 1, 2015 Pharma Tech Outlook recently conducted ... Clinical Data Management Solution Providers - 2015 .  After ... comprising CEOs, CIOs, VCs, analysts, and the Pharma Tech ... of top 10 clinical data management solution providers (check ... 14 and 36 respectively). --> ...
Breaking Medicine Technology: